Tissue of Origin: Lung
Cancer Type: Lung Small Cell Carcinoma
SK-LC-13 is a human lung cancer cell line.
This cell line was established from a lung metastasis from a person with lung small cell carcinoma.
- Lloyd J. Old, MD, former William E. Snee Chair in Cancer Immunology, MSK; former Director of the Ludwig Institute for Cancer Research
This cell line may be licensed nonexclusively for research or commercial purposes.
- Express License: For internal research purpMattes M.J., Cordon-Cardo C., Lewis J.L. Jr., Old L.J., Lloyd K.O. Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984) (PubMed ID 6582512)oses by a for-profit entity: Fill out MSK’s Core Express License; see here for links to the online fillable Core Express License, as well as a PDF version. For detailed guidance on how to fill out this webform, see here. Please note: In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. This license is only available for select cell lines, including this one. Once this license has been executed by MSK, you will receive a signed copy and payment instructions; all payments up to $10,000 must be made by credit card.
- Commercial License: Contact MSK’s Tangible Research Materials team at [email protected].
- For non-licensing requests from academic-research institutions: Contact MSK’s Antibody & Bioresource Core Facility at [email protected].